TY - JOUR
T1 - Regional Survey in Lombardy, Northern Italy, on Vascular Surgery Intervention Outcomes During The COVID-19 Pandemic
AU - Lombardy Covid-19 Vascular Study Group
AU - Bellosta, R.
AU - Piffaretti, G.
AU - Bonardelli, S.
AU - Castelli, P.
AU - Chiesa, R.
AU - Frigerio, D.
AU - Lanza, Gaetano
AU - Pirrelli, S.
AU - Rossi, G.
AU - Trimarchi, S.
AU - Briolini, F.
AU - Cefali, P.
AU - Caronno, R.
AU - Arzini, A.
AU - Diaco, D.
AU - Baratta, V.
AU - Aiello, S.
AU - Molinari, A.C.L.
AU - Socrate, A.M.
AU - Ferraris, M.
AU - Silvestro, A.
AU - Canu, G.
AU - Costantini, E.
AU - Logaldo, D.
AU - Lista, A.
AU - Busoni, C.
AU - Setti, M.
AU - Mezzetti, R.
AU - Bassi, L.
AU - Grassi, V.
AU - Kahlberg, A.
AU - Mascia, D.
AU - Ragni, F.
AU - Marone, E.M.
AU - Bozzani, A.
AU - Crippa, M.
AU - Stegher, S.
AU - Bonalumi, G.
N1 - Cited By :6
Export Date: 11 February 2022
PY - 2021
Y1 - 2021
N2 - Objective: The characteristics and outcomes of patients undergoing vascular surgery hospitalised and managed in Lombardy are described with a comparison of patients tested positive for COVID-19 (CV19-pos) vs. those tested negative (CV19-neg). Methods: This was a multicentre, retrospective, observational cohort study which involved all vascular surgery services in Lombardy, Northern Italy. Data were retrospectively merged into a combined dataset covering the nine weeks of the Italian COVID-19 pandemic phase 1 (8 March 2020 to 3 May 2020). The primary outcome was freedom from in hospital death, secondary outcomes were re-thrombosis rate after peripheral revascularisation, and freedom from post-operative complication. Results: Among 674 patients managed during the outbreak, 659 (97.8%) were included in the final analysis: 121 (18.4%) were CV19-pos. CV19-pos status was associated with a higher rate of complications (OR 4.5; p < .001, 95% CI 2.64 – 7.84), and a higher rate of re-thrombosis after peripheral arterial revascularisation (OR 2.2; p = .004, 95% CI 1.29 – 3.88). In hospital mortality was higher in CV19-pos patients (24.8% vs. 5.6%; OR 5.4, p < .001;95% CI 2.86 – 8.92). Binary logistic regression analysis identified CV19-pos status (OR 7.6; p < .001, 95% CI 3.75 – 15.28) and age > 80 years (OR 3.2; p = .001, 95% CI 1.61 – 6.57) to be predictors of in hospital death. Conclusion: In this experience of the vascular surgery group of Lombardy, COVID-19 infection was a marker of poor outcomes in terms of mortality and post-operative complications for patients undergoing vascular surgery treatments.
AB - Objective: The characteristics and outcomes of patients undergoing vascular surgery hospitalised and managed in Lombardy are described with a comparison of patients tested positive for COVID-19 (CV19-pos) vs. those tested negative (CV19-neg). Methods: This was a multicentre, retrospective, observational cohort study which involved all vascular surgery services in Lombardy, Northern Italy. Data were retrospectively merged into a combined dataset covering the nine weeks of the Italian COVID-19 pandemic phase 1 (8 March 2020 to 3 May 2020). The primary outcome was freedom from in hospital death, secondary outcomes were re-thrombosis rate after peripheral revascularisation, and freedom from post-operative complication. Results: Among 674 patients managed during the outbreak, 659 (97.8%) were included in the final analysis: 121 (18.4%) were CV19-pos. CV19-pos status was associated with a higher rate of complications (OR 4.5; p < .001, 95% CI 2.64 – 7.84), and a higher rate of re-thrombosis after peripheral arterial revascularisation (OR 2.2; p = .004, 95% CI 1.29 – 3.88). In hospital mortality was higher in CV19-pos patients (24.8% vs. 5.6%; OR 5.4, p < .001;95% CI 2.86 – 8.92). Binary logistic regression analysis identified CV19-pos status (OR 7.6; p < .001, 95% CI 3.75 – 15.28) and age > 80 years (OR 3.2; p = .001, 95% CI 1.61 – 6.57) to be predictors of in hospital death. Conclusion: In this experience of the vascular surgery group of Lombardy, COVID-19 infection was a marker of poor outcomes in terms of mortality and post-operative complications for patients undergoing vascular surgery treatments.
U2 - 10.1016/j.ejvs.2021.01.037
DO - 10.1016/j.ejvs.2021.01.037
M3 - Article
SN - 1078-5884
VL - 61
SP - 688
EP - 697
JO - European Journal of Vascular and Endovascular Surgery
JF - European Journal of Vascular and Endovascular Surgery
IS - 4
ER -